JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

Workday (NASDAQ:WDAY – Get Free Report)‘s stock had its “market outperform” rating reiterated by research analysts at JMP ...

JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...

Enova International (NYSE:ENVA – Free Report) had its target price upped by JMP Securities from $125.00 to $135.00 in a ...

JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...

JMP Securities analyst Greg P. Miller maintained a Buy rating on Equinix (EQIX – Research Report) today and set a price target of $1,200.00.

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

Wall Street analysts rerated Cloudflare, Inc (NYSE:NET) after the company released its fourth-quarterly print Thursday.

We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at where CyberArk Software Ltd. (NASDAQ:CYBR) stands against the other AI stocks.

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

Google parent Alphabet Inc. has been downgraded to market perform from market outperform by JMP Securities, with the analyst firm highlighting the potential impact of the company’s antitrust battle.